Skip to Main Content

Try STAT+ TODAY

Biogen

Most Read

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: The debate over data sharing heats up again

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Biogen is the latest pharma takeover target

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Biogen CEO to leave, Theranos hires compliance execs

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: FDA staff questions effectiveness of Merck antibiotic

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

Biogen puzzles Wall Street with plans to spin off its hemophilia business

All Coverage

Pharmalot Ed Silverman

Up and down the ladder: The latest comings and goings

Business Rebecca Robbins

Big Pharma’s big push to get patients to take their meds

advertisement

Politics Robert Weisman — Boston Globe

Biogen gets European OK for biosimilar drug